Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Huntington Beach › NPI 1437368511
Physician

Salem, Nahla

Salem, Nahla was paid $8.12M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.

33Billing provider infoSALEM, NAHLA
HUNTINGTON BEACH, CA 92647
33aNPI1437368511assigned 05/22/2007
28Total paid$8.12M
24GClaims182,357
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in California

Rank by total paid#47 of 2,511
Median peer was paid$13K
This provider vs. median632×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201824,614$1.04M
201931,614$1.46M
202025,784$1.11M
202134,503$1.45M
202244,720$1.97M
202318,414$887K
2024incomplete2,708$200K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 45% 52,690 41,750 $3.61M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24% 27,463 23,112 $1.96M
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 15% 15,801 14,935 $1.20M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 7.3% 8,577 6,268 $593K
15780 3.1% 438 304 $252K
96156 1.6% 2,176 2,128 $130K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1.4% 1,493 1,439 $117K
99070 <1% 8,186 7,366 $41K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 174 172 $22K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 208 208 $20K
G9920 Screening performed and negative <1% 595 593 $20K
93000 <1% 2,534 2,470 $19K
48 more codes
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,209 $18K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 553 $18K
99385 <1% 231 $18K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,410 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,693 $10K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 80 $9K
90674 <1% 281 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,511 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,652 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 577 $5K
96150 <1% 311 $4K
96151 <1% 277 $3K
99386 <1% 100 $3K
99496 <1% 14 $3K
90656 <1% 94 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 15,278 $2K
90686 <1% 59 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 141 $1K
G9919 Screening performed and positive and provision of recommendations <1% 32 $1K
81002 <1% 7,672 $624.54
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 34 $582.76
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 167 $543.24
81025 <1% 3,183 $493.20
36415 Collection of venous blood by venipuncture <1% 834 $440.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 31 $430.44
69210 <1% 130 $402.70
97602 <1% 659 $276.69
99000 <1% 1,376 $222.26
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 52 $200.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 33 $199.04
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 3,150 $135.60
99354 <1% 14 $134.94
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 856 $128.95
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,845 $49.40
86769 <1% 1,103 $44.61
36416 <1% 1,039 $35.34
81000 <1% 68 $30.27
82962 <1% 317 $22.14
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,044 $13.24
69209 <1% 66 $11.54
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications <1% 491 $0.01
57410 0% 26 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 12 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 19 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 14 $0.00
G8783 Normal blood pressure reading documented, follow-up not required 0% 220 $0.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 0% 41 $0.00
G8484 Influenza immunization was not administered, reason not given 0% 23 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.